Clinical Trial Update: Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation

View source ↗

Summary

A completed clinical trial from sponsor Natera is evaluating non-invasive cell-free DNA testing to replace invasive biopsies in heart transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant

Snippet

Sponsor: Natera, Inc. | Conditions: Heart Transplant | Status: COMPLETED